España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Boston Scientific
BSX
NYSE
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$103.04
0.33
0.32%
At close: -
$104.29
1.25
1.22%
After Hours: 7:53 PM EDT
Get Report
Comment
Q4 2024 Earnings in 6 days from now on Wed Feb 5th, before the market open
Conference call scheduled in 6 days at 8:00 AM
Click to view the webcast
Boston Scientific (BSX) Forecast
News
Earnings
Boston Scientific (BSX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Boston Scientific (NYSE:BSX) Stock
Boston Scientific Stock (NYSE: BSX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, January 29, 2025
$1000 Invested In Boston Scientific 5 Years Ago Would Be Worth This Much Today
Benzinga Insights
Tuesday, January 21, 2025
Top 4 Health Care Stocks You May Want To Dump In Q1
Avi Kapoor
Thursday, January 16, 2025
Boston Scientific To Present Data Supporting ...
Benzinga Newsdesk
Wednesday, January 15, 2025
$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today
Benzinga Insights
Wednesday, January 08, 2025
CNBC Halftime Report Final Trades: Apollo Glo...
Benzinga Newsdesk
Boston Scientific Expands Cardiovascular Treatment Portfolio With $440 Million+ Bolt Medical Deal
Vandana Singh
AAR Posts Upbeat Results, Joins AngioDynamics, eBay, Cal-Maine Foods And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
Boston Scientific shares are trading higher a...
Benzinga Newsdesk
Boston Scientific Enters Definitive Deal To A...
Benzinga Newsdesk
Friday, January 03, 2025
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Chris Katje
Thursday, January 02, 2025
Here's How Much $1000 Invested In Boston Scientific 10 Years Ago Would Be Worth Today
Benzinga Insights
Friday, December 20, 2024
Boston Scientific Updates Instructions for Cryoablation Balloons After Reports Of Severe Injuries
Vandana Singh
If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today
Benzinga Insights
Wednesday, December 18, 2024
Truist Securities Maintains Buy on Boston Sci...
Benzinga Newsdesk
Monday, December 16, 2024
JP Morgan Maintains Overweight on Boston Scie...
Benzinga Newsdesk
FDA Alerting About Potential Need For Early D...
Benzinga Newsdesk
Thursday, December 12, 2024
TD Cowen Maintains Buy on Boston Scientific, ...
Benzinga Newsdesk
Wednesday, December 11, 2024
Citigroup Maintains Buy on Boston Scientific,...
Benzinga Newsdesk
Key Takeaways From Boston Scientific Analyst Ratings
Benzinga Insights
Wells Fargo Maintains Overweight on Boston Sc...
Benzinga Newsdesk
Monday, December 09, 2024
Canaccord Genuity Maintains Buy on Boston Sci...
Benzinga Newsdesk
Tuesday, December 03, 2024
(BSX) - Analyzing Boston Scientific's Short Interest
Benzinga Insights
Insider Decision: Emily Woodworth Offloads $121K Worth Of Boston Scientific Stock
Benzinga Insights
Monday, December 02, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Friday, November 29, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Wednesday, November 27, 2024
Needham Reiterates Hold on Boston Scientific
Benzinga Newsdesk
Monday, November 25, 2024
$100 Invested In Boston Scientific 10 Years Ago Would Be Worth This Much Today
Benzinga Insights
Boston Scientific Enters Definitive Agreement...
Benzinga Newsdesk
Monday, November 18, 2024
Key Takeaways From Boston Scientific Analyst Ratings
Benzinga Insights
Why Is Medical Device Giant Boston Scientific Stock Trading Higher On Monday?
Vandana Singh
Needham Reiterates Hold on Boston Scientific
Benzinga Newsdesk
Boston Scientific shares are trading higher. ...
Benzinga Newsdesk
Reported Saturday, Boston Scientific's WATCHM...
Benzinga Newsdesk
Wednesday, November 13, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Monday, November 04, 2024
Boston Scientific Has Agreed To Acquire Corte...
Benzinga Newsdesk
Thursday, October 31, 2024
Needham Reiterates Hold on Boston Scientific
Benzinga Newsdesk
Wednesday, October 30, 2024
Why is Boston Scientific Stock Trading Lower On Wednesday?
Vandana Singh
Boston Scientific's ACURATE neo2 Aortic Valve...
Benzinga Newsdesk
Shares Of Boston Scientific See Volume; Compa...
Benzinga Newsdesk
Tuesday, October 29, 2024
$1000 Invested In This Stock 15 Years Ago Would Be Worth $11,000 Today
Benzinga Insights
Thursday, October 24, 2024
Bernstein Maintains Outperform on Boston Scie...
Benzinga Newsdesk
Morgan Stanley Maintains Overweight on Boston...
Benzinga Newsdesk
RBC Capital Maintains Outperform on Boston Sc...
Benzinga Newsdesk
Wells Fargo Maintains Overweight on Boston Sc...
Benzinga Newsdesk
Citigroup Maintains Buy on Boston Scientific,...
Benzinga Newsdesk
Canaccord Genuity Maintains Buy on Boston Sci...
Benzinga Newsdesk
Mizuho Maintains Outperform on Boston Scienti...
Benzinga Newsdesk
Needham Reiterates Hold on Boston Scientific
Benzinga Newsdesk
Wednesday, October 23, 2024
Boston Scientific Pauses Enrollment In Farapulse Study In Drug-Naive Patients With Irregular Heart Rhythm
Vandana Singh
Wall Street Slumps For Third Straight Day As Investor Sentiment Fades, Dollar Strength Resumes, Boeing Disappoints: What's Driving Markets Wednesday?
Piero Cingari
Show More